Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chronic hepatitis B virus infection].

Anca Trifan1, C Stanciu

  • 1Facultatea de Medicină, Institutul de Gastroenterologie şi Hepatologie Iaşi, Universitatea de Medicină şi Farmacie Gr.T. Popa Iaşi.

Revista Medico-Chirurgicala a Societatii De Medici Si Naturalisti Din Iasi
|February 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Romanian National Study on the Epidemiology of Inflammatory Bowel Diseases.

Journal of gastrointestinal and liver diseases : JGLD·2026
Same author

Beyond the Intestinal Mucosa in Long-Standing Inflammatory Bowel Disease: Consequences of Chronic Inflammation and Endoscopic Approaches to Diagnosis and Management.

Medicina (Kaunas, Lithuania)·2026
Same author

Natural products modulate social behavior and gut microbiota in a valproic acid-induced zebrafish model of autism spectrum disorder.

Biomolecules & biomedicine·2026
Same author

Mortality Attributable to Hepatitis B and C in Italy, Romania, and Spain, 2022 Estimates.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

A Comparative Study of Different Biological Drugs in First-Line Therapy in Crohn's Disease: A Multicenter Descriptive Analysis.

Medicina (Kaunas, Lithuania)·2026
Same author

The Role of Rotational Thromboelastometry in High-Risk-of-Bleeding Endoscopic Procedures in Patients with Decompensated Liver Cirrhosis.

Diagnostics (Basel, Switzerland)·2026

Chronic hepatitis B virus (HBV) infection impacts millions globally. Current treatments like alpha-interferon and lamivudine offer limited success, necessitating the development of more effective antiviral drugs for HBV.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Context:

  • Chronic hepatitis B virus (HBV) infection is a significant global health issue, affecting 350 million people worldwide.
  • Romania has a notable burden, with 1.1 million individuals affected.
  • Despite advancements, managing chronic HBV remains challenging, with treatments often yielding disappointing results.

Purpose:

  • To outline the treatment objectives for chronic hepatitis B, focusing on sustained suppression of HBV replication and liver disease remission.
  • To delineate treatment indications, specifically during the immune clearance phase after 3-6 months of surveillance, excluding immune tolerance and inactive carrier states.

Summary:

  • Current treatment options for chronic hepatitis B include alpha-interferon and lamivudine.

Related Experiment Videos

  • These therapies aim to control viral replication and manage liver disease progression.
  • The efficacy of existing treatments is suboptimal, highlighting the need for improved therapeutic strategies.

    • Impact:

    • The limitations of current therapies underscore the urgent requirement for novel, more potent antiviral drugs to effectively manage chronic hepatitis B.
    • Improved treatments could lead to better patient outcomes and reduced long-term liver disease complications.